A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
Clinical trial NCT00106548 · COMPLETED
Trial details
- NCT number
- NCT00106548
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 623
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.